Dysregulated long noncoding RNAs(lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells
Huo, Xiaoqi, Han, Shuanglin, Wu, Guang, Latchoumanin, Oliveir, Zhou, Gang, Hebbard, Lionel, George, Jacob, and Qiao, Liang (2017) Dysregulated long noncoding RNAs(lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells. Molecular Cancer, 16. 165.
|
PDF (Published Version)
- Published Version
Available under License Creative Commons Attribution. Download (924kB) | Preview |
Abstract
Hepatocellular carcinoma (HCC) is one of the most common malignant tumours with a poor prognosis worldwide. While early stage tumours can be treated with curative approaches such as liver transplantation or surgical resection, these are only suitable for a minority of patients. Those with advanced stage disease are only suitable for supportive approaches and most are resistant to the conventional chemotherapy or radiotherapy. Liver cancer stem cells (LCSCs) are a small subset of cancer cells with unlimited differentiation ability and tumour forming potential. In order to develop novel therapeutic approaches for HCC, we need to understand how the cancer develops and why treatment resistance occurs. Using high-throughput sequencing techniques, a large number of dysregulated long noncoding RNAs (lncRNAs) have been identified, and some of which are closely linked to key aspects of liver cancer pathology, progression, outcomes and for the maintenance of cancer stem cell-like properties. In addition, some lncRNAs are potential biomarkers for HCC diagnosis and may serve as the therapeutic targets. This review summarizes data recently reported lncRNAs that might be critical for the maintenance of the biological properties of LCSCs.
| Item ID: | 51338 |
|---|---|
| Item Type: | Article (Research - C1) |
| ISSN: | 1476-4598 |
| Keywords: | hepatocellular carcinoma (HCC); liver cancer stem cells (LCSCs); long non-coding RNAs (IncRNAs) |
| Additional Information: | This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| Funders: | Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney |
| Date Deposited: | 27 Oct 2017 00:14 |
| FoR Codes: | 32 BIOMEDICAL AND CLINICAL SCIENCES > 3211 Oncology and carcinogenesis > 321108 Molecular targets @ 100% |
| SEO Codes: | 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920102 Cancer and Related Disorders @ 100% |
| Downloads: |
Total: 1065 Last 12 Months: 11 |
| More Statistics |
Actions (Repository Staff Only)
 |
Item Control Page |